Dynavax Technologies | Aktie



Stock Lave om Dato
AbbVie USD 4.18B 269M 2024-12
Adma Biologics USD 170.24M 1.57M 2024-12
Amgen USD 7B 364M 2024-12
AstraZeneca USD 5.29B 374M 2024-12
Biogen USD 2.46B 8.7M 2024-12
BioMarin Pharmaceutical USD 1.23B 53.31M 2024-12
Bristol-Myers Squibb USD 2.56B 775M 2024-12
Dynavax Technologies USD 70.05M 7.65M 2024-12
Gilead Sciences USD 3.59B 154M 2024-12
Glaxosmithkline 5.92B 216M 2024-09
Merck USD 6.11B 135M 2024-12
Neurocrine Biosciences USD 57.4M 11.6M 2024-12
Novartis USD 5.72B 216M 2024-12
Pfizer USD 10.85B 870M 2024-12
Regeneron Pharmaceuticals USD 3.09B 69.3M 2024-12
Roche Holding CHF 7.61B 339M 2024-12
Sarepta Therapeutics USD 749.96M 184.04M 2024-12
TG Therapeutics 110.46M 25.79M 2024-12
Vertex Pharmaceuticals USD 1.21B 125.6M 2024-12



Dynavax Technologies Aktie - Aktuelle værdier, historiske data, prognoser, statistik, diagrammer og økonomisk kalender - Mar 2025.